Hepatitis C viral life cycle

Advanced Drug Delivery Reviews

Volumn 59, Issue 12, 2007, Pages 1200-1212

  Suzuki, Tetsuro ^a   Ishii, Koji ^a   Aizaki, Hideki ^a   Wakita, Takaji ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Hepatitis C virus; Polyprotein processing; RNA replication; Translation; Viral assembly

Indexed keywords

CHRONIC LIVER DISEASES; HEPATITIS C VIRUS; POLYPROTEIN PROCESSING; RNA REPLICATION; VIRAL ASSEMBLY; VIRAL PROTEINS;

CLONING; DISEASES; GENES; LIFE CYCLE; MOLECULAR BIOLOGY; PROTEINS; RNA;

VIRUSES;

CORE PROTEIN; GLYCOPROTEIN E1; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; P7 PROTEIN; POLYPROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; HEPATITIS C; HEPATITIS C VIRUS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; REVIEW; RNA TRANSLATION; VIRUS ASSEMBLY; VIRUS ENVELOPE; VIRUS GENOME; VIRUS HEPATITIS; VIRUS REPLICATION;

EUKARYOTIC CELLS; GENOME, VIRAL; HEPACIVIRUS; HUMANS; MODELS, BIOLOGICAL; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 35649001919     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.04.014     Document Type: Review

References (204)

1. Kuo G., Choo Q.-L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., Tegtmeier G.E., Bonino F., Colombo M., Lee W.-S., Kuo C., Berger K., Shuster F.R., Overby L.R., Bradley D.W., and Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244 (1989) 362-364
2. Grakoui A., Hanson H.L., and Rice C.M. Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis. Hepatology 33 3 (2001) 489-495
3. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 345 1 (2001) 41-52
4. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U. S. A. 87 17 (1990) 6547-6549
5. Alter M.J. Epidemiology of hepatitis C in the West. Semin. Liver Dis. 15 1 (1995) 5-14
6. Di Bisceglie M. Hepatitis C and hepatocellular carcinoma. Hepatology 26 3 Suppl 1 (1997) 34S-38S
7. Poynard T., Yuen M.F., Ratziu V., and Lai C.L. Viral hepatitis C. Lancet 362 9401 (2003) 2095-2100
8. Pawlotsky J.M. Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol. 12 2 (2004) 96-102
9. Houghton M., Weiner A., Han J., Kuo G., and Choo Q.-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14 (1991) 381-388
10. Robertson B., Myers G., Howard C., Brettin T., Bukh J., Gaschen B., Gojobori T., Maertens G., Mizokami M., Nainan O., Netesov S., Nishioka K., Shin i T., Simmonds P., Smith D., Stuyver L., and Weiner A. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch. Virol. 143 12 (1998) 2493-2503
11. Choo Q.-L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
12. Martell M., Esteban J.I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., and Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66 (1992) 3225-3229
13. Pawlotsky J.M. Hepatitis C virus population dynamics during infection. Curr. Top. Microbiol. Immunol. 299 (2006) 261-284
14. Bukh J., Purcell R.H., and Miller R.H. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 89 11 (1992) 4942-4946
15. Brown E.A., Zhang H., Ping L.H., and Lemon S.M. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res. 20 19 (1992) 5041-5045
16. Honda M., Beard M.R., Ping L.H., and Lemon S.M. A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J. Virol. 73 2 (1999) 1165-1174
17. Honda M., Brown E.A., and Lemon S.M. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 2 10 (1996) 955-968
18. Tsukiyama-Kohara K., Iizuka N., Kohara M., and Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J. Virol. 66 (1992) 1476-1483
19. Wang C., Sarnow P., and Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 67 (1993) 3338-3344
20. Friebe P., Lohmann V., Krieger N., and Bartenschlager R. Sequences in the 5′ nontranslated region of hepatitis C virus required for RNA replication. J. Virol. 75 24 (2001) 12047-12057
21. Jopling L., Yi M., Lancaster A.M., Lemon S.M., and Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309 5740 (2005) 1577-1581
22. Ito T., and Lai M.M. An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3′-untranslated sequence. Virology 254 2 (1999) 288-296
23. Kolykhalov A., Agapov E.V., Blight K.J., Mihalik K., Feinstone S.M., and Rice C.M. Transmission of hepatitis C by intrahepatic inoculation with transcibed RNA. Science 277 (1997) 570-574
24. Tanaka T., Kato N., Cho M.-J., and Shimotohno K. A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem. Biophys. Res. Commun. 215 (1995) 744-749
25. Yi M., and Lemon S.M. 3′ nontranslated RNA signals required for replication of hepatitis C virus RNA. J. Virol. 77 6 (2003) 3557-3568
26. Friebe P., and Bartenschlager R. Genetic analysis of sequences in the 3′ nontranslated region of hepatitis C virus that are important for RNA replication. J. Virol. 76 11 (2002) 5326-5338
27. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Ohkoshi S., and Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem. Biophys. Res. Commun. 175 (1991) 220-228
28. Weiner J., Brauer M.J., Rosenblatt J., Richman K.H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q.-L., and Houghton M. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180 (1991) 842-848
29. Kato N., Ootsuyama Y., Tanaka T., Nakagawa M., Nakazawa T., Muraiso K., Ohkoshi S., Hijikata M., and Shimotohno K. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res. 22 (1992) 107-123
30. Harada S., Watanabe Y., Takeuchi K., Suzuki T., Katayama T., Takebe Y., Saito I., and Miyamura T. Expression of processed core protein of hepatitis C virus in mammalian cells. J. Virol. 65 (1991) 3015-3021
31. Liu Q., Tackney C., Bhat R.A., Prince A.M., and Zhang P. Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J. Virol. 71 1 (1997) 657-662
32. Suzuki R., Tamura K., Li J., Ishii K., Matsuura Y., Miyamura T., and Suzuki T. Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus. Virology 280 2 (2001) 301-309
33. Yasui K., Wakita T., Tsukiyama-Kohara K., Funahashi S.I., Ichikawa M., Kajita T., Moradpour D., Wands J.R., and Kohara M. The native form and maturation process of hepatitis C virus core protein. J. Virol. 72 7 (1998) 6048-6055
34. Selby J., Choo Q.-L., Berger K., Kuo G., Glazer E., Eckart M., Lee C., Chien D., Kuo C., and Houghton M. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J. Gen. Virol. 74 (1993) 1103-1113
35. Suzuki R., Matsuura Y., Suzuki T., Ando A., Chiba J., Harada S., Saito I., and Miyamura T. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J. Gen. Virol. 76 (1995) 53-61
36. Moradpour D., Wakita T., Tokushige K., Carlson R.I., Krawczynski K., and Wands J.R. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. J. Med. Virol. 48 3 (1996) 234-241
37. Barba G., Harper F., Harada T., Kohara M., Goulinet S., Matsuura Y., Eder G., Schaff Z., Chapman M.J., Miyamura T., and Brechot C. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1200-1205
38. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., and Kimura S. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4 (1998) 1065-1067
39. Hope R.G., and McLauchlan J. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J. Gen. Virol. 81 Pt 8 (2000) 1913-1925
40. Okuda M., Li K., Beard M.R., Showalter L.A., Scholle F., Lemon S.M., and Weinman S.A. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122 2 (2002) 366-375
41. Schwer B., Ren S., Pietschmann T., Kartenbeck J., Kaehlcke K., Bartenschlager R., Yen T.S., and Ott M. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J. Virol. 78 15 (2004) 7958-7968
42. Suzuki R., Sakamoto S., Tsutsumi T., Rikimaru A., Tanaka K., Shimoike T., Moriishi K., Iwasaki T., Mizumoto K., Matsuura Y., Miyamura T., and Suzuki T. Molecular determinants for subcellular localization of hepatitis C virus core protein. J. Virol. 79 2 (2005) 1271-1281
43. Moriishi K., Mochizuki R., Moriya K., Miyamoto H., Mori Y., Abe T., Murata S., Tanaka K., Miyamura T., Suzuki T., Koike K., and Matsuura Y. Critical role of PA28{gamma} in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 104 5 (2007) 1661-1666
44. Moriishi K., Okabayashi T., Nakai K., Moriya K., Koike K., Murata S., Chiba T., Tanaka K., Suzuki R., Suzuki T., Miyamura T., and Matsuura Y. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J. Virol. 77 19 (2003) 10237-10249
45. Shirakura M., Murakami K., Ichimura T., Suzuki R., Shimoji T., Fukuda K., Abe K., Sato S., Fukasawa M., Yamakawa Y., Nishijima M., Moriishi K., Matsuura Y., Wakita T., Suzuki T., Howley P.M., Miyamura T., and Shoji I. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J. Virol. 81 3 (2007) 1174-1185
46. Suzuki T., and Suzuki R. Maturation and assembly of hepatitis C virus core protein. In: Kalitzky M., and Borowski P. (Eds). Molecular Biology of the Flavivirus (2006), Horizon Bioscience, Norfolk, U.K. 295-311
47. Op De Beeck A., Cocquerel L., and Dubuisson J. Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol. 82 Pt 11 (2001) 2589-2595
48. Cocquerel L., Op de Beeck A., Lambot M., Roussel J., Delgrange D., Pillez A., Wychowski C., Penin F., and Dubuisson J. Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins. EMBO J. 21 12 (2002) 2893-2902
49. Nakai K., Okamoto T., Kimura-Someya T., Ishii K., Lim C.K., Tani H., Matsuo E., Abe T., Mori Y., Suzuki T., Miyamura T., Nunberg J.H., Moriishi K., and Matsuura Y. Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein. J. Virol. 80 22 (2006) 11265-11273
50. Sakai A., Claire M.S., Faulk K., Govindarajan S., Emerson S.U., Purcell R.H., and Bukh J. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc. Natl. Acad. Sci. U. S. A. 100 20 (2003) 11646-11651
51. Pavlovic D., Neville D.C., Argaud O., Blumberg B., Dwek R.A., Fischer W.B., and Zitzmann N. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc. Natl. Acad. Sci. U. S. A. 100 10 (2003) 6104-6108
52. Griffin S.D., Beales L.P., Clarke D.S., Worsfold O., Evans S.D., Jaeger J., Harris M.P., and Rowlands D.J. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett. 535 1-3 (2003) 34-38
53. Grakoui A., McCourt D.W., Wychowski C., Feinstone S.M., and Rice C.M. A second hepatitis C virus-encoded proteinase. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10583-10587
54. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., and Shimotohno K. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67 (1993) 4665-4675
55. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (1999) 110-113
56. Khromykh A., and Westaway E.G. Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 71 2 (1997) 1497-1505
57. Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L., and Bartenschlager R. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. U. S. A. 103 19 (2006) 7408-7413
58. Kolykhalov A., Mihalik K., Feinstone S.M., and Rice C.M. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J. Virol. 74 (2000) 2046-2051
59. Lorenz C., Marcotrigiano J., Dentzer T.G., and Rice C.M. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature 442 7104 (2006) 831-835
60. De Francesco R., and Migliaccio G. Challenges and successes in developing new therapies for hepatitis C. Nature 436 7053 (2005) 953-960
61. Wolk B., Sansonno D., Krausslich H.G., Dammacco F., Rice C.M., Blum H.E., and Moradpour D. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J. Virol. 74 5 (2000) 2293-2304
62. Kim L., Morgenstern K.A., Lin C., Fox T., Dwyer M.D., Landro J.A., Chambers S.P., Markland W., Lepre C.A., O'Malley E.T., Harbeson S.L., Rice C.M., Murcko M.A., Caron P.R., and Thomson J.A. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87 (1996) 343-355
63. Love R.A., Parge H.E., Wickersham J.A., Hostomsky Z., Habuka N., Moomaw E.W., Adachi T., and Hostomska Z. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 87 (1996) 331-342
64. Yan Y., Li Y., Munshi S., Sardana V., Cole J.L., Sardana M., Steinkuehler C., Tomei L., De Francesco R., Kuo L.C., and Chen Z. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form. Protein Sci. 7 4 (1998) 837-847
65. Kwong D., Kim J.L., and Lin C. Structure and function of hepatitis C virus NS3 helicase. Curr. Top. Microbiol. Immunol. 242 (2000) 171-196
66. Kim L., Morgenstern K.A., Griffith J.P., Dwyer M.D., Thomson J.A., Murcko M.A., Lin C., and Caron P.R. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6 1 (1998) 89-100
67. Serebrov V., and Pyle A.M. Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase. Nature 430 6998 (2004) 476-480
68. Levin M.K., Gurjar M., and Patel S.S. A Brownian motor mechanism of translocation and strand separation by hepatitis C virus helicase. Nat. Struct. Mol. Biol. 12 5 (2005) 429-435
69. Dumont S., Cheng W., Serebrov V., Beran R.K., Tinoco Jr. I., Pyle A.M., and Bustamante C. RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP. Nature 439 7072 (2006) 105-108
70. Frick D.N., Rypma R.S., Lam A.M., and Gu B. The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. J. Biol. Chem. 279 2 (2004) 1269-1280
71. Lundin M., Monne M., Widell A., Von Heijne G., and Persson M.A. Topology of the membrane-associated hepatitis C virus protein NS4B. J. Virol. 77 9 (2003) 5428-5438
72. Egger D., Wolk B., Gosert R., Bianchi L., Blum H.E., Moradpour D., and Bienz K. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76 12 (2002) 5974-5984
73. Gao L., Aizaki H., He J.W., and Lai M.M. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J. Virol. 78 7 (2004) 3480-3488
74. Tellinghuisen T.L., Marcotrigiano J., Gorbalenya A.E., and Rice C.M. The NS5A protein of hepatitis C virus is a zinc metalloprotein. J. Biol. Chem. 279 47 (2004) 48576-48587
75. Tellinghuisen T.L., Marcotrigiano J., and Rice C.M. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435 7040 (2005) 374-379
76. Blight K.J., Kolykhalov A.A., and Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science 290 (2000) 1972-1974
77. Krieger N., Lohmann V., and Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75 10 (2001) 4614-4624
78. Lohmann V., Korner F., Dobierzewska A., and Bartenschlager R. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 75 3 (2001) 1437-1449
79. Shimakami T., Hijikata M., Luo H., Ma Y.Y., Kaneko S., Shimotohno K., and Murakami S. Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon. J. Virol. 78 6 (2004) 2738-2748
80. Shirota Y., Luo H., Qin W., Kaneko S., Yamashita T., Kobayashi K., and Murakami S. Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J. Biol. Chem. 277 13 (2002) 11149-11155
81. Dimitrova M., Imbert I., Kieny M.P., and Schuster C. Protein-protein interactions between hepatitis C virus nonstructural proteins. J. Virol. 77 9 (2003) 5401-5414
82. Moradpour D., Brass V., Bieck E., Friebe P., Gosert R., Blum H.E., Bartenschlager R., Penin F., and Lohmann V. Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J. Virol. 78 23 (2004) 13278-13284
83. Schmidt-Mende J., Bieck E., Hugle T., Penin F., Rice C.M., Blum H.E., and Moradpour D. Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J. Biol. Chem. 276 47 (2001) 44052-44063
84. Ago H., Adachi T., Yoshida A., Yamamoto M., Habuka N., Yatsunami K., and Miyano M. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Struct. Fold. Des. 7 11 (1999) 1417-1426
85. Lesburg A., Cable M.B., Ferrari E., Hong Z., Mannarino A.F., and Weber P.C. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat. Struct. Mol. Biol. 6 10 (1999) 937-943
86. Bressanelli S., Tomei L., Rey F.A., and De Francesco R. Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. J. Virol. 76 7 (2002) 3482-3492
87. Butcher S.J., Grimes J.M., Makeyev E.V., Bamford D.H., and Stuart D.I. A mechanism for initiating RNA-dependent RNA polymerization. Nature 410 6825 (2001) 235-240
88. Baumert T.F., Ito S., Wong D.T., and Liang T.J. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J. Virol. 72 5 (1998) 3827-3836
89. Matsuo E., Tani H., Lim C., Komoda Y., Okamoto T., Miyamoto H., Moriishi K., Yagi S., Patel A.H., Miyamura T., and Matsuura Y. Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem. Biophys. Res. Commun. 340 1 (2006) 200-208
90. Lagging L.M., Randall K.M., Owens J., and Ray R. Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus. J. Virol. 72 (1998) 3539-3546
91. Matsuura Y., Tani H., Suzuki K., Kimura-Someya T., Suzuki R., Aizaki H., Ishii K., Moriishi K., Robison C.S., Whitt M.A., and Miyamura T. Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286 2 (2001) 263-275
92. Bartosch B., Bukh J., Meunier J.C., Granier C., Engle R.E., Blackwelder W.C., Emerson S.U., Cosset F.L., and Purcell R.H. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc. Natl. Acad. Sci. U. S. A. 100 24 (2003) 14199-14204
93. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., and McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U. S. A. 100 12 (2003) 7271-7276
94. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 7 (2005) 791-796
95. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102 26 (2005) 9294-9299
96. Lindenbach D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 5734 (2005) 623-626
97. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
98. Levy S., Todd S.C., and Maecker H.T. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16 (1998) 89-109
99. Petracca R., Falugi F., Galli G., Norais N., Rosa D., Campagnoli S., Burgio V., Di Stasio E., Giardina B., Houghton M., Abrignani S., and Grandi G. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 74 10 (2000) 4824-4830
100. Bartosch B., Dubuisson J., and Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197 5 (2003) 633-642
101. Cormier E.G., Tsamis F., Kajumo F., Durso R.J., Gardner J.P., and Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 101 19 (2004) 7270-7274
102. Zhang J., Randall G., Higginbottom A., Monk P., Rice C.M., and McKeating J.A. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78 3 (2004) 1448-1455
103. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., Scarselli E., Cortese R., Nicosia A., and Cosset F.L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278 43 (2003) 41624-41630
104. McKeating A., Zhang L.Q., Logvinoff C., Flint M., Zhang J., Yu J., Butera D., Ho D.D., Dustin L.B., Rice C.M., and Balfe P. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J. Virol. 78 16 (2004) 8496-8505
105. Lavillette D., Tarr A.W., Voisset C., Donot P., Bartosch B., Bain C., Patel A.H., Dubuisson J., Ball J.K., and Cosset F.L. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41 2 (2005) 265-274
106. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., and Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21 19 (2002) 5017-5025
107. Rhainds D., and Brissette L. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders. Int. J. Biochem. Cell Biol. 36 1 (2004) 39-77
108. Yamada E., Montoya M., Schuettler C.G., Hickling T.P., Tarr A.W., Vitelli A., Dubuisson J., Patel A.H., Ball J.K., and Borrow P. Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets. J. Gen. Virol. 86 Pt 9 (2005) 2507-2512
109. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 5248 (1996) 518-520
110. Landschulz K.T., Pathak R.K., Rigotti A., Krieger M., and Hobbs H.H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 98 4 (1996) 984-995
111. Barth H., Cerino R., Arcuri M., Hoffmann M., Schurmann P., Adah M.I., Gissler B., Zhao X., Ghisetti V., Lavezzo B., Blum H.E., von Weizsacker F., Vitelli A., Scarselli E., and Baumert T.F. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. J. Virol. 79 9 (2005) 5774-5785
112. Bartosch B., Verney G., Dreux M., Donot P., Morice Y., Penin F., Pawlotsky J.M., Lavillette D., and Cosset F.L. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J. Virol. 79 13 (2005) 8217-8229
113. Lavillette D.D., Morice Y., Germanidis G., Donot P., Soulier A., Pagkalos E., Sakellariou G., Intrator L., Bartosch B., Pawlotsky J.M., and Cosset F.L. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J. Virol. 79 10 (2005) 6023-6034
114. Meunier J.C., Engle R.E., Faulk K., Zhao M., Bartosch B., Alter H., Emerson S.U., Cosset F.L., Purcell R.H., and Bukh J. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl. Acad. Sci. U. S. A. 102 12 (2005) 4560-4565
115. Voisset C., Callens N., Blanchard E., Op De Beeck A., Dubuisson J., and Vu-Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J. Biol. Chem. 280 9 (2005) 7793-7799
116. Gardner J.P., Durso R.J., Arrigale R.R., Donovan G.P., Maddon P.J., Dragic T., and Olson W.C. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 100 8 (2003) 4498-4503
117. Lozach Y., Lortat-Jacob H., de Lacroix de Lavalette A., Staropoli I., Foung S., Amara A., Houles C., Fieschi F., Schwartz O., Virelizier J.L., Arenzana-Seisdedos F., and Altmeyer R. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem. 278 22 (2003) 20358-20366
118. Pohlmann S., Zhang J., Baribaud F., Chen Z., Leslie G.J., Lin G., Granelli-Piperno A., Doms R.W., Rice C.M., and McKeating J.A. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77 7 (2003) 4070-4080
119. Saunier B., Triyatni M., Ulianich L., Maruvada P., Yen P., and Kohn L.D. Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J. Virol. 77 1 (2003) 546-559
120. Cormier E.G., Durso R.J., Tsamis F., Boussemart L., Manix C., Olson W.C., Gardner J.P., and Dragic T. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 101 39 (2004) 14067-14072
121. Lozach Y., Amara A., Bartosch B., Virelizier J.L., Arenzana-Seisdedos F., Cosset F.L., and Altmeyer R. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J. Biol. Chem. 279 31 (2004) 32035-32045
122. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. U. S. A. 96 22 (1999) 12766-12771
123. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., and Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446 7137 (2007) 801-805
124. Rijnbrand R., Bredenbeek P., van der Straaten T., Whetter L., Inchauspe G., Lemon S., and Spaan W. Almost the entire 5′ non-translated region of hepatitis C virus is required for cap-independent translation. FEBS Lett. 365 2-3 (1995) 115-119
125. Yoo B.J., Spaete R.R., Geballe A.P., Selby M., Houghton M., and Han J.H. 5′ end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5′ untranslated region. Virology 191 2 (1992) 889-899
126. Hellen U., and Pestova T.V. Translation of hepatitis C virus RNA. J. Viral Hepatitis 6 2 (1999) 79-87
127. Lu H.H., and Wimmer E. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 93 4 (1996) 1412-1417
128. Reynolds J.E., Kaminski A., Kettinen H.J., Grace K., Clarke B.E., Carroll A.R., Rowlands D.J., and Jackson R.J. Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J. 14 23 (1995) 6010-6020
129. Spahn M., Kieft J.S., Grassucci R.A., Penczek P.A., Zhou K., Doudna J.A., and Frank J. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 291 5510 (2001) 1959-1962
130. Otto A., and Puglisi J.D. The pathway of HCV IRES-mediated translation initiation. Cell 119 3 (2004) 369-380
131. Ali N., Pruijn G.J., Kenan D.J., Keene J.D., and Siddiqui A. Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J. Biol. Chem. 275 36 (2000) 27531-27540
132. Ali N., and Siddiqui A. The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc. Natl. Acad. Sci. U. S. A. 94 6 (1997) 2249-2254
133. Isoyama T., Kamoshita N., Yasui K., Iwai A., Shiroki K., Toyoda H., Yamada A., Takasaki Y., and Nomoto A. Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. J. Gen. Virol. 80 Pt 9 (1999) 2319-2327
134. Hahm B., Kim Y.K., Kim J.H., Kim T.Y., and Jang S.K. Heterogeneous nuclear ribonucleoprotein L interacts with the 3′ border of the internal ribosomal entry site of hepatitis C virus. J. Virol. 72 11 (1998) 8782-8788
135. Fukushi I.S., Okada M., Kageyama T., Hoshino F.B., Nagai K., and Katayama K. Interaction of poly(rC)-binding protein 2 with the 5′-terminal stem loop of the hepatitis C-virus genome. Virus Res. 73 1 (2001) 67-79
136. Anwar A., Ali N., Tanveer R., and Siddiqui A. Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site-mediated translation initiation. J. Biol. Chem. 275 44 (2000) 34231-34235
137. Shimoike T., Mimori S., Tani H., Matsuura Y., and Miyamura T. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J. Virol. 73 12 (1999) 9718-9725
138. Tanaka Y., Shimoike T., Ishii K., Suzuki R., Suzuki T., Ushijima H., Matsuura Y., and Miyamura T. Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5′ untranslated region of the viral genome. Virology 270 1 (2000) 229-236
139. Shimoike T., Koyama C., Murakami K., Suzuki R., Matsuura Y., Miyamura T., and Suzuki T. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein. Virology 345 2 (2006) 434-445
140. Zhang J., Yamada O., Yoshida H., Iwai T., and Araki H. Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus. Virology 293 1 (2002) 141-150
141. Li D., Takyar S.T., Lott W.B., and Gowans E.J. Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells. J Gen Virol 84 Pt 4 (2003) 815-825
142. Wang T.H., Rijnbrand R.C., and Lemon S.M. Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J. Virol. 74 23 (2000) 11347-11358
143. Walewski J.L., Keller T.R., Stump D.D., and Branch A.D. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7 5 (2001) 710-721
144. Xu Z., Choi J., Yen T.S., Lu W., Strohecker A., Govindarajan S., Chien D., Selby M.J., and Ou J. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20 14 (2001) 3840-3848
145. Varaklioti A., Vassilaki N., Georgopoulou U., and Mavromara P. Alternate translation occurs within the core coding region of the hepatitis C viral genome. J. Biol. Chem. 277 20 (2002) 17713-17721
146. Hüssy P., Langen H., Mous J., and Jacobsen H. Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology 224 (1996) 93-104
147. McLauchlan J., Lemberg M.K., Hope G., and Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 21 15 (2002) 3980-3988
148. Lemberg M.K., and Martoglio B. Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol. Cell 10 4 (2002) 735-744
149. Okamoto K., Moriishi K., Miyamura T., and Matsuura Y. Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J. Virol. 78 12 (2004) 6370-6380
150. Weihofen A., Binns K., Lemberg M.K., Ashman K., and Martoglio B. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296 5576 (2002) 2215-2218
151. Bartenschlager R., Ahlborn-Laake L., Mous J., and H. Jacobsen. Kinetic and structural analyses of hepatitis C virus polyprotein processing. J. Virol. 68 (1994) 5045-5055
152. Failla C., Tomei L., and De Francesco R. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J. Virol. 69 3 (1995) 1769-1777
153. Lin C., Pragai B.M., Grakoui A., Xu J., and Rice C.M. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J. Virol. 68 (1994) 8147-8157
154. Tanji Y., Hijikata M., Hirowatari Y., and Shimotohno K. Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinase-dependent cleavage. J. Virol. 68 (1994) 8418-8422
155. Aizaki H., Lee K.J., Sung V.M., Ishiko H., and Lai M.M. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324 2 (2004) 450-461
156. Ali N., Tardif K.D., and Siddiqui A. Cell-free replication of the hepatitis C virus subgenomic replicon. J. Virol. 76 23 (2002) 12001-12007
157. Lai V.C., Dempsey S., Lau J.Y., Hong Z., and Zhong W. In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus. J. Virol. 77 3 (2003) 2295-2300
158. Miyanari Y., Hijikata M., Yamaji M., Hosaka M., Takahashi H., and Shimotohno K. Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication. J. Biol. Chem. 278 50 (2003) 50301-50308
159. Hardy R.W., Marcotrigiano J., Blight K.J., Majors J.E., and Rice C.M. Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells. J. Virol. 77 3 (2003) 2029-2037
160. Shi S.T., Lee K.J., Aizaki H., Hwang S.B., and Lai M.M. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J. Virol. 77 7 (2003) 4160-4168
161. Pfeifer U., Thomssen R., Legler K., Bottcher U., Gerlich W., Weinmann E., and Klinge O. Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees. Virchows Arch., B Cell Pathol. Incl. Mol. Pathol. 33 3 (1980) 233-243
162. Mottola G., Cardinali G., Ceccacci A., Trozzi C., Bartholomew L., Torrisi M.R., Pedrazzini E., Bonatti S., and Migliaccio G. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 293 1 (2002) 31-43
163. Pietschmann T., Lohmann V., Rutter G., Kurpanek K., and Bartenschlager R. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J. Virol. 75 3 (2001) 1252-1264
164. Waris G., Sarker S., and Siddiqui A. Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA 10 2 (2004) 321-329
165. Umehara T., Sudoh M., Yasui F., Matsuda C., Hayashi Y., Chayama K., and Kohara M. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model. Biochem. Biophys. Res. Commun. 346 1 (2006) 67-73
166. Sakamoto H., Okamoto K., Aoki M., Kato H., Katsume A., Ohta A., Tsukuda T., Shimma N., Aoki Y., Arisawa M., Kohara M., and Sudoh M. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat. Chem. Biol. 1 6 (2005) 333-337
167. Hamamoto I., Nishimura Y., Okamoto T., Aizaki H., Liu M., Mori Y., Abe T., Suzuki T., Lai M.M., Miyamura T., Moriishi K., and Matsuura Y. Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J. Virol. 79 21 (2005) 13473-13482
168. Okamoto T., Nishimura Y., Ichimura T., Suzuki K., Miyamura T., Suzuki T., Moriishi K., and Matsuura Y. Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO J. 25 20 (2006) 5015-5025
169. Ye J., Wang C., Sumpter Jr. R., Brown M.S., Goldstein J.L., and Gale Jr. M. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc. Natl. Acad. Sci. U. S. A. 100 26 (2003) 15865-15870
170. Kapadia S.B., and Chisari F.V. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. U. S. A. 102 7 (2005) 2561-2566
171. Tan T.L., Nakao H., He Y., Vijaysri S., Neddermann P., Jacobs B.L., Mayer B.J., and Katze M.G. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc. Natl. Acad. Sci. U. S. A. 96 10 (1999) 5533-5538
172. Ghosh K., Majumder M., Steele R., Yaciuk P., Chrivia J., Ray R., and Ray R.B. Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J. Biol. Chem. 275 10 (2000) 7184-7188
173. Chung K.M., Lee J., Kim J.E., Song O.K., Cho S., Lim J., Seedorf M., Hahm B., and Jang S.K. Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3. J. Virol. 74 11 (2000) 5233-5241
174. Burckstummer T., Kriegs M., Lupberger J., Pauli E.K., Schmittel S., and Hildt E. Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication. FEBS Lett. 580 2 (2006) 575-580
175. Ikeda M., Abe K., Yamada M., Dansako H., Naka K., and Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44 1 (2006) 117-125
176. Watashi K., Ishii N., Hijikata M., Inoue D., Murata T., Miyanari Y., and Shimotohno K. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell 19 1 (2005) 111-122
177. Goh P.Y., Tan Y.J., Lim S.P., Tan Y.H., Lim S.G., Fuller-Pace F., and Hong W. Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication. J. Virol. 78 10 (2004) 5288-5298
178. Hirano M., Kaneko S., Yamashita T., Luo H., Qin W., Shirota Y., Nomura T., Kobayashi K., and Murakami S. Direct interaction between nucleolin and hepatitis C virus NS5B. J. Biol. Chem. 278 7 (2003) 5109-5115
179. Shimakami T., Honda M., Kusakawa T., Murata T., Shimotohno K., Kaneko S., and Murakami S. Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon. J. Virol. 80 7 (2006) 3332-3340
180. Kim S., Seol S.K., Song O.K., Park J.H., and Jang S.K. An RNA-binding protein, hnRNP A1, and a scaffold protein, Septin 6, facilitate hepatitis C virus replication. J. Virol. 81 8 (2007) 3852-3865
181. Ali N., and Siddiqui A. Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J. Virol. 69 10 (1995) 6367-6375
182. Ito T., and Lai M.M. Determination of the secondary structure of and cellular protein binding to the 3′-untranslated region of the hepatitis C virus RNA genome. J. Virol. 71 11 (1997) 8698-8706
183. Murakami K., Abe M., Kageyama T., Kamoshita N., and Nomoto A. Down-regulation of translation driven by hepatitis C virus internal ribosomal entry site by the 3′ untranslated region of RNA. Arch. Virol. 146 4 (2001) 729-741
184. Tsuchihara K., Tanaka T., Hijikata M., Kuge S., Toyoda H., Nomoto A., Yamamoto N., and Shimotohno K. Specific interaction of polypyrimidine tract-binding protein with the extreme 3′-terminal structure of the hepatitis C virus genome, the 3′X. J. Virol. 71 9 (1997) 6720-6726
185. Aizaki H., Choi K.S., Liu M., Li Y.J., and Lai M.M. Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis. J. Biomed. Sci. 13 4 (2006) 469-480
186. Kaito M., Wastanabe S., Tsukiyama-Kohara K., Yamaguchi K., Kobayashi Y., Konishi M., Yokoi M., Ishida S., Suzuki S., and Kohara M. Hepatitis C virus particle detected by immunoelectron microscopic study. J. Gen. Virol. 75 (1994) 1755-1760
187. Shimizu Y.K., Feinstone S.M., Kohara M., Purcell R.H., and Yoshikura H. Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology 23 (1996) 205-209
188. Maillard P., Krawczynski K., Nitkiewicz J., Bronnert C., Sidorkiewicz M., Gounon P., Dubuisson J., Faure G., Crainic R., and Budkowska A. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J. Virol. 75 17 (2001) 8240-8250
189. Andre P., Komurian-Pradel F., Deforges S., Perret M., Berland J.L., Sodoyer M., Pol S., Brechot C., Paranhos-Baccala G., and Lotteau V. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76 14 (2002) 6919-6928
190. Kunkel M., Lorinczi M., Rijnbrand R., Lemon S.M., and Watowich S.J. Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J. Virol. 75 5 (2001) 2119-2129
191. Lorenzo L.J., Duenas-Carrera S., Falcon V., Acosta-Rivero N., Gonzalez E., de la Rosa M.C., Menendez I., and Morales J. Assembly of truncated HCV core antigen into virus-like particles in Escherichia coli. Biochem. Biophys. Res. Commun. 281 4 (2001) 962-965
192. Acosta-Rivero N., Aguilar J.C., Musacchio A., Falcon V., Vina A., de la Rosa M.C., and Morales J. Characterization of the HCV core virus-like particles produced in the methylotrophic yeast Pichia pastoris. Biochem. Biophys. Res. Commun. 287 1 (2001) 122-125
193. Blanchard E., Hourioux C., Brand D., Ait-Goughoulte M., Moreau A., Trassard S., Sizaret P.Y., Dubois F., and Roingeard P. Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111. J. Virol. 77 18 (2003) 10131-10138
194. Majeau N., Gagne V., Boivin A., Bolduc M., Majeau J.A., Ouellet D., and Leclerc D. The N-terminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation. J. Gen. Virol. 85 Pt 4 (2004) 971-981
195. Klein C., Polyak S.J., and Lingappa J.R. Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J. Virol. 78 17 (2004) 9257-9269
196. Matsumoto M., Hwang S.B., Jeng K.S., Zhu N., and Lai M.M. Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 218 1 (1996) 43-51
197. Nolandt O., Kern V., Muller H., Pfaff E., Theilmann L., Welker R., and Krausslich H.G. Analysis of hepatitis C virus core protein interaction domains. J. Gen. Virol. 78 Pt 6 (1997) 1331-1340
198. Yan S., Tam M.H., and Syu W.J. Self-association of the C-terminal domain of the hepatitis-C virus core protein. Eur. J. Biochem. 258 1 (1998) 100-106
199. Ezelle H.J., Markovic D., and Barber G.N. Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector. J. Virol. 76 23 (2002) 12325-12334
200. Murakami K., Ishii K., Ishihara Y., Yoshizaki S., Tanaka K., Gotoh Y., Aizaki H., Kohara M., Yoshioka H., Mori Y., Manabe N., Shoji I., Sata T., Bartenschlager R., Matsuura Y., Miyamura T., and Suzuki T. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. Virology 351 2 (2006) 381-392
201. Lo S.-Y., Selby M.J., and Ou J.-H. Interaction between hepatitis C virus core protein and E1 envelope protein. J. Virol. 70 (1996) 5177-5182
202. Ma H.C., Ke C.H., Hsieh T.Y., and Lo S.Y. The first hydrophobic domain of the hepatitis C virus E1 protein is important for interaction with the capsid protein. J. Gen. Virol. 83 Pt 12 (2002) 3085-3092
203. Serafino A., Valli M.B., Andreola F., Crema A., Ravagnan G., Bertolini L., and Carloni G. Suggested role of the Golgi apparatus and endoplasmic reticulum for crucial sites of hepatitis C virus replication in human lymphoblastoid cells infected in vitro. J. Med. Virol. 70 1 (2003) 31-41
204. Sato K., Okamoto H., Aihara S., Hoshi Y., Tanaka T., and Mishiro S. Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans. Virology 196 (1993) 354-357